Auto-antibodies in autoimmune hepatitis: Anti-smooth muscle antibodies (ASMA)

Clinics and Research in Hepatology and Gastroenterology

Volumn 36, Issue 2, 2012, Pages 189-191

  Johanet, Catherine ^a   Ballot, Eric ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; F ACTIN; IMMUNOSUPPRESSIVE AGENT; SMOOTH MUSCLE ANTIBODY;

ARTICLE; AUTOIMMUNE HEPATITIS; CELIAC DISEASE; CONNECTIVE TISSUE DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LAMINA PROPRIA; LIVER CELL CARCINOMA; LIVER DISEASE; NONHUMAN; PATHOGENESIS; PROGNOSIS; PROTEIN ANALYSIS; SENSITIVITY AND SPECIFICITY; TOXIC HEPATITIS; TREATMENT RESPONSE; VIRUS HEPATITIS; VIRUS INFECTION;

ANIMALS; AUTOANTIBODIES; HEPATITIS, AUTOIMMUNE; HUMANS; MUSCLE, SMOOTH;

EID: 84858619661     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2011.10.012     Document Type: Article

References (21)

1. Alvarez F., Berg P.A., Bianchi F.B., Bianchi L., Burroughs A.K., Cancado E.L., et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999, 31:929-938.
2. Hennes E.M., Zeniya M., Czaja A.J., Parés A., Dalekos G.N., Krawitt E.L., et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008, 48:169-176.
3. Obermayer-Straub P., Strassburg C.P., Manns M.P. Autoimmune hepatitis. J Hepatol 2000, 32:181-197.
4. Chretien-Leprince P., Ballot E., Andre C., Olsson N.O., Fabien N., Escande A., et al. Diagnostic value of anti-F-actin antibodies in a French multicenter study. Ann N Y Acad Sci 2005, 1050:266-273.
5. Villalta D., Bizzaro N., Da Re M., Tozzoli R., Komorowski L., Tonutti E. Diagnostic accuracy of four different immunological methods for the detection of anti-F-actin auto-antibodies in type 1 autoimmune hepatitis and other liver-related disorders. Autoimmunity 2008, 41:105-110.
6. Johnson G.D., Holborow E.J., Glynn L.E. Antibody to smooth muscle in patients with liver disease. Lancet 1965, 2:878-879.
7. Gabbiani G., Graeme B.R., Lamelin J.P., Vassalli P., Majno G., Bouvier C.A., et al. Human smooth muscle auto-antibody. Its identification as anti-actin antibody and a study of its binding to nonmuscular cells. Am J Pathol 1973, 72:473-488.
8. Gueguen P., Dalekos G., Nousbaum J.B., Zachou K., Putterman C., Youinou P., et al. Double reactivity against actin and alpha-actinin defines a severe form of autoimmune hepatitis type 1. J Clin Immunol 2006, 26:495-505.
9. Bottazzo G.F., Florin Christensen A., Failax A., Iwana G., Doniach D., Groeschel-Stevart U. Classification of smooth muscle auto-antibodies detected by immunofluorescence. J Clin Pathol 1976, 29:403-410.
10. Granito A., Muratori L., Muratori P., Pappas G., Guidi M., Cassani F., et al. Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis. J Clin Pathol 2006, 59:280-284.
11. Soares A., Cunha R., Rodrigues F., Ribeiro H. Smooth muscle auto-antibodies with F-actin specificity. Autoimmun Rev 2009, 8:713-716.
12. Muratori L., Muratori P., Granito A., Pappas G., Cassani F., Lenzi M. Current topics in autoimmune hepatitis. Dig Liver Dis 2010, 42:757-764.
13. Toh B.H., Taylor R., Pollock W., Dearden S., Gill C.C., Buchner C., et al. Actin-reactive discriminated from non-actin-reactive smooth muscle auto-antibody by immunofluorescence reactivity with rat epithelial cell line. Pathology 2010, 42:463-469.
14. Bogdanos D.P., Invernizzi P., Mackay I.R., Vergani D. Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol 2008, 14:3374-3387.
15. Muratori P., Granito A., Pappas G., Pendino G.M., Quarneti C., Cicola R., et al. The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. Am J Gastroenterol 2009, 104:1420-1425.
16. Frenzel C., Herkel J., Lüth S., Galle P.R., Schramm C., Lohse A.W. Evaluation of F-actin Elisa for the diagnosis of autoimmune hepatitis. Am J Gastroenterol 2006, 101:2731-2736.
17. Mehendiratta V., Mitroo P., Bombonati A., Navarro V.J., Rossi S., Rubin R., et al. Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis. Clin Gastroenterol Hepatol 2009, 7:98-103.
18. Czaja A.J., Cassani F., Cataleta M., Valentini P., Bianchi F.B. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology 1996, 24:1068-1073.
19. Gregorio G.V., McFarlane B., Bracken P., Vergani D., Mieli-Vergani G. Organ and non-organ specific auto-antibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease. Autoimmunity 2002, 35:515-519.
20. Dalekos G.N., Zachou K., Liaskos C., Gatselis N. Auto-antibodies and defined target auto-antigens in autoimmune hepatitis: an overwiew. Eur J Int Med 2002, 13:293-303.
21. Longhi M.S., Ma Y., Mieli-Vergani G., Vergani D. Aetiopathogenesis of autoimmune hepatitis. J Autoimmun 2010, 34:7-14.